Otilimab Begins Phase 3 Clinical Studies for RA
Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis
Measles Is Back. How Does This Affect Patients with Rheumatic Disease?
Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
Drug Assistance Programs Offer Little Charity to Uninsured
Baricitinib: Early vs. Late Treatment Outcomes in RA Patients
Secukinumab: The Real World Experience of PsA Patients
White House Preparing Order that Would Cut Drug Prices for Medicare
Drug Makers Met with Trump to Argue against Senate Pricing Bill
- 1
- 2
- 3
- …
- 95
- Next Page »